• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情期间印度平衡医疗保健与经济的经验

Balancing Healthcare and Economy Amidst the COVID-19 Pandemic: An Indian Experience.

作者信息

Dhar Ruby, Jee Babban, Karmakar Subhradip

机构信息

Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.

Department of Health Research, Ministry of Health and Family Welfare, Government of India, New Delhi, India.

出版信息

Risk Manag Healthc Policy. 2021 Feb 26;14:827-833. doi: 10.2147/RMHP.S291084. eCollection 2021.

DOI:10.2147/RMHP.S291084
PMID:33664604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7924119/
Abstract

With its 1.3 billion population and faced with the COVID-19 pandemic, India is at the junction of two crucial decisions, balancing healthcare and the economy. To prevent the community spread of the virus, the Indian Government imposed a nationwide lockdown. Though initially successful to some extent in containing the disease spread, the extended lockdown eventually leads to a spiraling out effect resulting in the slowdown of the economy, which, in turn, lead to widespread consequences affecting the lives of millions of people, mostly those at the base of the social pyramid. We investigated the implications of few government policies taken during this pandemic and their impact on society, thereby suggesting short-term crisis management with long-term solutions. Here, we present a comprehensive account of Indian policy in dealing with the COVID-19 crisis, balancing both economic and public health. We also explored a future contingency plan for risk mitigation along with few recommendations. This viewpoint will be useful for effective healthcare management and the economy in Asia's populous nation in the COVID-19 and prepare for a future crisis of this nature.

摘要

印度拥有13亿人口,且面临新冠疫情,正处于两个关键决策的交汇点,即在医疗保健和经济之间寻求平衡。为防止病毒在社区传播,印度政府实施了全国范围的封锁。尽管最初在一定程度上成功遏制了疾病传播,但延长的封锁最终导致了一种螺旋式的负面影响,致使经济放缓,进而产生了广泛的后果,影响了数百万人的生活,其中大多数是社会金字塔底层的人群。我们研究了疫情期间政府采取的一些政策的影响及其对社会的冲击,从而提出了兼具短期危机管理和长期解决方案的建议。在此,我们全面阐述了印度应对新冠疫情危机的政策,兼顾了经济和公共卫生两方面。我们还探索了未来的风险缓解应急计划并给出了一些建议。这一观点对于这个亚洲人口大国在新冠疫情期间进行有效的医疗管理和经济调控,并为未来此类性质的危机做好准备将有所助益。

相似文献

1
Balancing Healthcare and Economy Amidst the COVID-19 Pandemic: An Indian Experience.新冠疫情期间印度平衡医疗保健与经济的经验
Risk Manag Healthc Policy. 2021 Feb 26;14:827-833. doi: 10.2147/RMHP.S291084. eCollection 2021.
2
Migrant in my own country: The long march of migrant workers in India during the COVID-19 pandemic 2020-Failure of postcolonial governments to decolonize Bihar and rebuild Indian civilization after 1947.我自己国家的“移民”:2020年新冠疫情期间印度农民工的漫长征程——后殖民政府在1947年后未能使比哈尔邦非殖民化并重建印度文明。
J Family Med Prim Care. 2020 Oct 30;9(10):5087-5091. doi: 10.4103/jfmpc.jfmpc_2045_20. eCollection 2020 Oct.
3
Effects of the COVID-19 pandemic in India: An analysis of policy and technological interventions.2019年冠状病毒病疫情对印度的影响:政策与技术干预措施分析
Health Policy Technol. 2021 Mar;10(1):151-164. doi: 10.1016/j.hlpt.2020.12.001. Epub 2020 Dec 25.
4
Can India stay immune enough to combat COVID-19 pandemic? An economic query.印度能否保持足够的免疫力来抗击新冠疫情?一个经济学疑问。
J Public Aff. 2020 Nov;20(4):e2157. doi: 10.1002/pa.2157. Epub 2020 Jun 19.
5
A qualitative analysis of social scientists' opinions on socioeconomic and demographic implications of the lockdown during COVID-19 in India.对社会科学家关于印度新冠疫情封锁期间社会经济和人口影响的观点进行的定性分析。
J Public Aff. 2021 Aug;21(3):e2531. doi: 10.1002/pa.2531. Epub 2020 Oct 22.
6
The 5% of the Population at High Risk for Severe COVID-19 Infection Is Identifiable and Needs to Be Taken Into Account When Reopening the Economy.新冠病毒严重感染高风险的5%人群是可识别的,在经济重启时需要予以考虑。
J Psychiatr Pract. 2020 May;26(3):219-227. doi: 10.1097/PRA.0000000000000475.
7
COVID-19 pandemic in China: Context, experience and lessons.中国的新冠疫情:背景、经验与教训
Health Policy Technol. 2020 Dec;9(4):639-648. doi: 10.1016/j.hlpt.2020.08.006. Epub 2020 Aug 27.
8
Psychosocial and Socio-Economic Crisis in Bangladesh Due to COVID-19 Pandemic: A Perception-Based Assessment.孟加拉国因 COVID-19 大流行而导致的心理社会和社会经济危机:基于认知的评估。
Front Public Health. 2020 Jun 26;8:341. doi: 10.3389/fpubh.2020.00341. eCollection 2020.
9
COVID-19: The need for an Australian economic pandemic response plan.新冠疫情:澳大利亚制定经济应对大流行计划的必要性。
Health Policy Technol. 2020 Dec;9(4):488-502. doi: 10.1016/j.hlpt.2020.08.017. Epub 2020 Aug 28.
10
COVID-19 Lessons and Post-pandemic Recovery: A Case of Latvia.新冠疫情的经验教训与疫情后复苏:拉脱维亚案例
Front Public Health. 2022 Apr 7;10:866639. doi: 10.3389/fpubh.2022.866639. eCollection 2022.

引用本文的文献

1
COVID-19 vaccination acceptance and adherence among pregnant and lactating high-risk group individuals of Maharashtra State, India.印度马哈拉施特拉邦孕妇和哺乳期高危人群对新冠疫苗的接受度和依从性
J Educ Health Promot. 2023 Jan 31;12:36. doi: 10.4103/jehp.jehp_204_22. eCollection 2023.
2
Behind the Frontline: A Review on the Impact of COVID-19 Pandemic on Healthcare Workers.前线背后:关于新冠疫情对医护人员影响的综述
Cureus. 2022 Sep 20;14(9):e29349. doi: 10.7759/cureus.29349. eCollection 2022 Sep.
3
Coronavirus pandemic in the Nordic countries: Health policy and economy trade-off.北欧国家的冠状病毒大流行:卫生政策与经济权衡。
J Glob Health. 2022 Aug 8;12:05017. doi: 10.7189/jogh.12.05017.
4
Burden of COVID-19 and case fatality rate in Pune, India: an analysis of the first and second wave of the pandemic.印度浦那新冠肺炎负担及病死率:对疫情第一波和第二波的分析
IJID Reg. 2022 Mar;2:74-81. doi: 10.1016/j.ijregi.2021.12.006. Epub 2021 Dec 18.

本文引用的文献

1
JOINT STATEMENT ON DATA PROTECTION AND PRIVACY IN THE COVID-19 RESPONSE.关于新冠疫情应对中数据保护与隐私的联合声明。
Neurosciences (Riyadh). 2021 Jan;26(1):111-112.
2
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.巴瑞替尼联合瑞德西韦治疗住院的新冠成年患者
N Engl J Med. 2021 Mar 4;384(9):795-807. doi: 10.1056/NEJMoa2031994. Epub 2020 Dec 11.
3
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.用于治疗新冠肺炎的抗病毒药物 repurposed - 世界卫生组织团结试验中期结果
N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.
4
Private Health Sector in India-Ready and Willing, Yet Underutilized in the Covid-19 Pandemic: A Cross-Sectional Study.印度私营医疗行业——有准备且愿意,但在新冠疫情期间未得到充分利用:一项横断面研究。
Front Public Health. 2020 Oct 16;8:571419. doi: 10.3389/fpubh.2020.571419. eCollection 2020.
5
Vaccines for COVID-19.COVID-19 疫苗。
Clin Exp Immunol. 2020 Nov;202(2):162-192. doi: 10.1111/cei.13517. Epub 2020 Oct 18.
6
A living WHO guideline on drugs for covid-19.关于新冠病毒药物的世界卫生组织实用指南。
BMJ. 2020 Sep 4;370:m3379. doi: 10.1136/bmj.m3379.
7
Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis.氯喹和羟氯喹治疗 COVID-19 的系统评价和荟萃分析。
J Gen Intern Med. 2020 Nov;35(11):3308-3314. doi: 10.1007/s11606-020-06146-w. Epub 2020 Sep 3.
8
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial.羟氯喹治疗非住院的 COVID-19 轻症成年患者:一项随机试验。
Ann Intern Med. 2020 Oct 20;173(8):623-631. doi: 10.7326/M20-4207. Epub 2020 Jul 16.
9
The Covid-19 Vaccine-Development Multiverse.新冠疫苗研发多元世界。
N Engl J Med. 2020 Nov 12;383(20):1986-1988. doi: 10.1056/NEJMe2025111. Epub 2020 Jul 14.
10
Vaccines for COVID-19: The current state of play.COVID-19 疫苗:当前进展状况。
Paediatr Respir Rev. 2020 Sep;35:43-49. doi: 10.1016/j.prrv.2020.06.010. Epub 2020 Jun 18.